100
Participants
Start Date
August 31, 2006
Primary Completion Date
July 31, 2008
Study Completion Date
July 31, 2008
Acamprosate (Campral)
The study is a double-blind, randomized, placebo-controlled clinical trial in which participants will receive 333 mg t.i.d. oral acamprosate or matching placebo for a 12-week period. Each participant will also receive brief behavioral intervention at each visit.
UNC Family Medicine Center, Chapel Hill
Center for Addiction and Behavioral Health Research University of Wisconsin-Milwaukee, Milwaukee
University of Wisconsin, Milwaukee
OTHER
University of North Carolina, Chapel Hill
OTHER